中樞腦血管病_第1頁(yè)
中樞腦血管病_第2頁(yè)
中樞腦血管病_第3頁(yè)
中樞腦血管病_第4頁(yè)
中樞腦血管病_第5頁(yè)
已閱讀5頁(yè),還剩73頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

CentralNervousSystem南京醫(yī)科大學(xué)一附院放射科洪汛寧hongxunning@10/4/20231第1頁(yè)TheFiveMostCommonStrokeSymptomsSuddennumbnessorweaknessofface,armorleg,especiallyononesideofthebody.Suddenconfusion,troublespeakingorunderstanding.Suddentroubleseeinginoneorbotheyes.Suddentroublewalking,dizziness,lossofbalanceorcoordination.Suddensevereheadachewithnoknowncause.(Source:NationalStrokeAssociation)10/4/20232第2頁(yè)OtherImportantbutLessCommonStrokeSymptomsSuddennausea,feverandvomitingdistinguishedfromaviralillnessbythespeedofonset(minutesorhoursvs.severaldays).Brieflossofconsciousnessorperiodofdecreasedconsciousness(fainting,confusion,convulsionsorcoma).Source:NationalStrokeAssociation10/4/20233第3頁(yè)ClinicalFeaturesDependsonvascularterritoryinvolvedUsuallyabruptonsetMostprecise:levelsofconsciousness(LOC),grossmotorlevelLeastprecise:sensoryexam,history(includingTIA)Clinicalexamperformanceimproveswithtraining10/4/20234第4頁(yè)腦血管疾病

(cerebrovasculardisease)腦梗死(cerebralinfarction)腦出血(intracranialhemorrhage)動(dòng)靜脈畸形(aterio-venousmalformation)蛛網(wǎng)膜下腔出血(subarachnoidhemorrhage)和顱內(nèi)動(dòng)脈瘤(intracranialaneurysm)10/4/20235第5頁(yè)

TheconsequencesofcerebralischemiadependonthedegreeanddurationofreducedCBF.Neuronscantolerateischemiafor30-60minutes.Perfusionmustbereestablishedbefore3-6hoursofischemiahaveelapsedorbeforetheCBFdropsto10.腦梗死cerebralinfarction10/4/20236第6頁(yè)cerebralinfarctionPathologicchangeswithintheneuropilfollowthemetabolicabnormalities.OneofthefirsteffectsiscytotoxicedemathatresultsfromfailureoftheNa/Kionpump.Earlyon,thisstageisstillreversible.Prolongedischemialeadstocelldeathandcoagulationnecrosis.After3-6hoursofischemia,irreversibledamageoccurstothecapillaryendothelium.10/4/20237第7頁(yè)CTandMRscansinpatientswithasymptomaticbruitsorTIA'sareusuallynegative.Theearliestsignmaybeabnormalvasculardensity/signal.ThefirstparenchymalchangesobservedonCTandMRreflectthecytotoxicedemaaffectingprimarilythegraymatter.ischemiccerebralinfarction10/4/20238第8頁(yè)ItisimportanttorememberthattheCTscanmaybenegativeforthefirst24-48hours.Massiveinfarctionsmaybevisibleasearlyas6hours.TheMRscanisusuallypositivewithinthreetofourhoursfollowingastroke.OneoftheearliersignsonCTislossofthenormalgray-whitecontrastastheedematouscortexbecomesisodensetotheunderlyingwhitematter.After6-8hourstheaccompanyingvasogenicedemahighlightstheareasofbraininfarction.ischemiccerebralinfarction10/4/20239第9頁(yè)CTCT掃描見(jiàn)低密度灶。常呈扇形,基底貼近顱內(nèi)板,尖指向顱腦中心。初期(1~2天)邊界較模糊,中后期(2~7天)邊界較清,無(wú)占位征或略有占位征。病灶部位和范疇與閉塞血管旳所屬供血區(qū)域一致1~3周時(shí)可浮現(xiàn)模糊效應(yīng)(側(cè)支循環(huán)建立)增強(qiáng)掃描可呈輕度腦回狀強(qiáng)化(血腦屏破壞及側(cè)循建立)1~2月后可浮現(xiàn)低密度腦軟化或伴腦萎縮。注:24小時(shí)內(nèi)檢出率低,24~48小時(shí)后檢出率高,2天~2周水腫較明顯。10/4/202310第10頁(yè)TopographicVascularSupply

(Http://www.C/nm-Mediabook/figures/brainfigs.Html)10/4/202311第11頁(yè)ACATerritoryStroke10/4/202312第12頁(yè)P(yáng)CATerritoryInfarct10/4/202313第13頁(yè)RightPICAStroke

(/~c064s01/nr251.htm)10/4/202314第14頁(yè)

male56yearsold,

150minaftersymptom常規(guī)CTTimetoPeakCBF隨訪顱內(nèi)動(dòng)脈栓塞隨訪CT顯示液化灶10/4/202315第15頁(yè)Cerebralinfarction10/4/202316第16頁(yè)10/4/202317第17頁(yè)10/4/202318第18頁(yè)10/4/202319第19頁(yè)HyperacuteStroke:CT

(Koeller,AFIPStrokeLecture)HyperdensearteryBasalgangliaobscuredInsularribbonlostEdema:sulcalorventriculareffacement10/4/202320第20頁(yè)HyperdenseMCASignPrognosticValueoftheHyperdenseMiddleCerebralArterySignandStrokeScaleScorebeforeUltraearlyThrombolyticTherapyAJNRAmJNeuroradiol17:79–85,January199610/4/202321第21頁(yè)HyperdenseRightMCA10/4/202322第22頁(yè)AxialunenhancedCTimageobtainedina53-year-oldmanshowshypoattenuationandobscurationoftheleftlentiformnucleus(arrows),which,becauseofacuteischemiainthelenticulostriatedistribution,appearsabnormalincomparisonwiththerightlentiformnucleus.10/4/202323第23頁(yè)ObscurationoftheRightBasalGangliainAcuteStroke

(AJNRAmJNeuroradiol17:1743–1748)10/4/202324第24頁(yè)AxialunenhancedCTimages,obtainedina45-year-oldman2hoursaftertheonsetoflefthemiparesis,showobscurationoftherightlentiformnucleus(arrowinb).Thisfeatureislessvisiblewiththeroutinebrainimagingwindowusedfora(windowwidth,80HU;center,35HU)thanwiththenarrowerwindowusedforb(windowwidth,10HU;center,28HU).10/4/202325第25頁(yè)MRI檢出腦梗塞較CT敏感。梗塞6小時(shí)內(nèi),細(xì)胞毒性水腫,梗塞區(qū)含水量高,T1、T2時(shí)間延長(zhǎng)。6小時(shí)后漸浮現(xiàn)血管源性腦水腫,血腦屏障破壞。較高檔MR應(yīng)用MRI彌散成像和灌注成像,能更初期發(fā)現(xiàn)病灶,有助于初期治療。10/4/202326第26頁(yè)DIFFUSION&PERFUSIONIMAGING

ConventionalCTandMRimagingarenotsufficientlysensitivetoevaluateacutestroke.Theultimategoalforimagingistodefinetheareaofbraininfarctionandperfusiondeficit,andtoidentifyanyischemictissuethatcanbesalvagedbymedicalorsurgicaltherapy.DWIcandetectacutebraininfarctionwithin1to2hours.Perfusionimagingispositiveimmediatelyfollowinganacutestroke.10/4/202327第27頁(yè)AcuteRightMCAStroke10/4/202328第28頁(yè)AcuteMCAStrokewithDiffusion

10/4/202329第29頁(yè)4P’sofAcuteStrokeImaging?Parenchyma–Assesearlysigns,excludehemorrhagePipes–Assessextra&intracranialcirculationPerfusion–AssessCBV,CBF,&MTT

Penumbra–Assesstissueatriskofdying10/4/202330第30頁(yè)HemorrhagicInfarct

(Koeller,AFIPStrokeLecture) 10%ofacutestroke.

HigherincidenceinAsianpopulation. <24hours. Anticoagulationcontraindicated.10/4/202331第31頁(yè)HemorrhagicCerebralInfarction10/4/202332第32頁(yè)HemorrhagicStroke

AJNRAmJNeuroradiol18:1011–1020,June199710/4/202333第33頁(yè)HemorrhagicTransformation

(Koeller,AFIPStrokeLecture) >24hoursafterinfarctbydefinition Peak:1-2weeks Diapedesis血細(xì)胞滲出Occursafterreperfusion:thefullpressureofarterialbloodintohypoxiccapillariesresultsinadiapedesisorredcellsmovingthroughthevesselhypoxicwalls Occursinupto50%ofstrokes Confirmsischemicnatureofinfarct10/4/202334第34頁(yè)HemorrhagicTransformation

/AANLIB/cases/case42/mr1/012.html10/4/202335第35頁(yè)腔隙性腦梗死lacunarinfarction丘腦基底節(jié)區(qū)或深部腦髓質(zhì)小血管(A)閉塞所致CT征象:于好發(fā)部位見(jiàn)小旳低密度灶,一般為1~1.5cm大小,初期邊界較模糊,中晚期邊界較清MRI檢查腔梗灶較CT敏感高,初期更易發(fā)現(xiàn)10/4/202336第36頁(yè)lacunarinfarction10/4/202337第37頁(yè)MRIT2WI,T1WI,flairlacunarinfarction10/4/202338第38頁(yè)存在問(wèn)題致死率及致殘率10/4/202339第39頁(yè)影像學(xué)研究方略腦梗死前期腦缺血旳影像學(xué)研究Hypo-PbeforeIS10/4/202340第40頁(yè)IntracranialHemorrhageVerycommonTrauma,Hypertension;Aneurysm;VascularMalformationOthers:Embolicstrokewithreperfusion;Amyloidangiopathy;Coagulopathies;Drugabuse;Tumor10/4/202341第41頁(yè)CTofIntracranialHemorrhage

Allcerebralhematomas,whateverthecause,haveasimilarresolutionpatternonCT.Therateofresolutiondependsonthesizeofthehematoma,usuallywithinonetosixweeks,andtheyresorbfromtheoutsidetowardthecenter.Perihematomalowdensityappearsin24-48hours.Rimenhancementappearsinoneweekandpersistsforsixweeks.Theendresultofahematomaisdecreasedparenchymaldensity,focalatrophyandlocalventriculardilatation.10/4/202342第42頁(yè)10/4/202343第43頁(yè)10/4/202344第44頁(yè)10/4/202345第45頁(yè)腦內(nèi)血腫(T1,T2,turbo-T2)其內(nèi)有陳舊性出血10/4/202346第46頁(yè)腦干出血10/4/202347第47頁(yè)發(fā)病當(dāng)時(shí)CT發(fā)病兩年后MRI復(fù)查10/4/202348第48頁(yè)腦血管畸形(AVM)影像可以明確診斷,還可以觀測(cè)大小及血供狀況,常有腦萎縮目前重要是血管成像(DSA、CTA、MRA等)可直接顯示畸形血管10/4/202349第49頁(yè)CTCTfeaturesofanAVmalformationonplainscanincludeahigh-absorptionirregularmasswithlargefeedingarteriesanddrainingveins,focalareasofcalcificationandnosurroundingedemaormasseffect.Thecontrastscanshowsserpiginousenhancementwithprominentarteriesandveins.10/4/202350第50頁(yè)MRIThebestMRAsequencesfordepictingtheanatomyofAVmalformationsare3D

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論